Fig. 2From: Intravenous iron and erythropoietin therapy for postoperative anemia among orthopedic surgery patientsChanges in iron metabolism parameters. Serum iron levels following IV iron monotherapy (Group 1, A), combined IV iron and rHuEPO therapy (Group 2, B), and placebo (Control, C). Serum transferrin saturation following IV iron monotherapy (Group 1, D), following combined IV iron and rHuEPO therapy (Group 2, E), and placebo (Control, F). Serum ferritin levels following IV iron monotherapy (Group 1, G), combined IV iron and rHuEPO therapy (Group 2, H), and placebo (Control, I). Serum hepcidin levels following IV iron monotherapy (Group 1, J), combined IV iron and rHuEPO therapy (Group 2, K), and placebo (Control, L)Back to article page